Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.

Arslan D., Tural D., KOCA T., TAŞTEKİN D., CERKESLI A. K., BASARAN H., ...Daha Fazla

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.20, sa.2, ss.573-9, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2015
  • Dergi Adı: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.573-9
  • Anahtar Kelimeler: clinical stage T4N2, locally advanced non-small cell lung cancer, patient outcome, prognostic factors, treatment modality, survival, SOUTHWEST-ONCOLOGY-GROUP, PHASE-II, INDUCTION CHEMOTHERAPY, POOLED ANALYSIS, CONCURRENT, RADIOTHERAPY, SURVIVAL, CHEMORADIOTHERAPY, PACLITAXEL, CISPLATIN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: Relatively few studies have focused on T4N2 (stage IIIB) locally advanced non-small cell lung cancer (NSCLC). In this study, we tried to identify prognostic factors for patients with clinical stage T4N2 NSCLC.